Skip to main content
. 2016 Apr 20;7(22):32990–33003. doi: 10.18632/oncotarget.8843

Figure 6. Combination treatment and inhibition of tumor growth in BGC-823 xenograft nude mice.

Figure 6

A. The animal weight and RTV were examined in vivo. B. Representative photographs of tumors respectively, in each group at the end of experiment. C. The cleaved PARP and p-ERK1/2 were checked by western blot analysis in DT-13-TPT combination-treated group. D-E. Tumor tissues from BGC-823-xenografted nude mice after DT-13-TPT combination treatment were analyzed by TUNEL assays, and immunohistochemistry staining of cleaved caspase-3, p-ERK, Cav-1, EGFR and NM IIA. Statistical analysis was performed using one-way ANOVA followed by Bonferroni's Multiple Comparison Test, *P< 0.05; **P< 0.01; ***P< 0.001.